Tech Giants Quanta, ASUS, and Gigabyte Foresee Transformative Trends in Medical AI at IBMI 2024 Annual General Meeting

The IBMI 2024 Annual General Meeting commenced on March 4th, with a focus on "Foreseeing Transformative Trends in Medical AI." This year's conference aims to explore the latest applications of AI in healthcare.

Barry Lam, founder of the Quanta Group and IBMI Vice President, highlighted the vast potential of generative AI to revolutionize the medical landscape, offering groundbreaking solutions to the health industry. He urged academia, healthcare systems, and the IT industry to engage in interdisciplinary collaboration, leveraging AI and IT power to address practical medical challenges.

AI: The Core of Future Healthcare, Key to Precision Health

Jonney Shih, Chairman of ASUS, presented the Healthcare 4.0 initiative as a pivotal driver of future healthcare services. He emphasized how digital technologies not only resolve critical issues in life sciences and medical care but also expedite the digital transformation of the healthcare sector, ushering in personalized precision health, expansive virtual care, and heightened operational resilience for healthcare institutions.

Mr. Shih underscored AI's role in empowering future healthcare scenarios, significantly strengthening and optimizing hospital digital transformations. The ultimate goal is to construct intelligent healthcare systems that seamlessly integrate virtual and real realms, propelling healthcare services into a new era.

Emerging AI Solutions: Bridging Urban-Rural Healthcare Gaps and Aging Challenges

In parallel, Pei-Chen Yeh, Chairman of Gigabyte, highlighted the symbiotic relationship between data, computing power, and algorithms in propelling AI development. He underscored Taiwan's wealth of medical data within its National Health Insurance system and the comprehensive experience of medical professionals, advocating for their fusion with cutting-edge technologies to bridge urban-rural healthcare disparities and address aging populations.

He stressed the contemporary need for comprehensive health protection beyond mere medical services. Through the establishment of a robust big data repository and the application of AI analytics, this objective can be rapidly achieved. He expressed confidence in the proliferation of AI applications in the future, offering substantial support for medicine and pharmaceuticals' advancement and presenting an opportune moment for ICT companies to leverage their strengths.

Medical Technology Joins Forces: Healthcare Expo+ Taiwan - Leading the Largest AI Healthcare Event in APAC

Taiwan drives innovation in medical tech for precision and preventive medicine. Each year, the Expo convenes leading global tech firms such as Acer, ASUS, Inventec, Quanta, Quisda, and Wistron, showcasing state-of-the-art healthcare applications.

Now in its eighth year, the expo promises to unveil the latest breakthroughs in Healthtech, Medtech, and Biotech. With a track record of over 200,000 attendees, 650 institutions, and 1,500 international buyers and hospital directors in 2023, this year's Expo aims to forge strategic alliances, connecting global medical and tech partners to accelerate global medical digital transformation and foster innovation.

【2024 Healthcare Expo+ Taiwan】
Date: December 05-08, 2024
Place: Hall 1, Taipei Nangang Exhibition Center
Apply to Exhibit:
(Interested exhibitors are encouraged to apply early as the first-stage booth selection ends in March)

Information appearing on this website (images and texts, unless otherwise indicated) is the property of IBMI. To use or share, please indicate the source.
© 2024 Institute for Biotechnology and Medicine Industry (IBMI) All rights reserved.
Address:16F.-1, No.3, Park St., Nangang Dist., Taipei City 115, Taiwan (R.O.C.) Contact Number:(02)2655-8168 Fax:(02)2655-7978